Novartis Ag (NVS) Inventory Average (2018 - 2025)
Novartis Ag (NVS) has disclosed Inventory Average for 8 consecutive years, with $6.0 billion as the latest value for Q4 2025.
- Quarterly Inventory Average rose 3.06% to $6.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.0 billion through Dec 2025, up 3.06% year-over-year, with the annual reading at $6.0 billion for FY2025, 3.06% up from the prior year.
- Inventory Average hit $6.0 billion in Q4 2025 for Novartis Ag, up from $5.8 billion in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $6.9 billion in Q4 2022 to a low of $5.8 billion in Q4 2024.
- Historically, Inventory Average has averaged $6.4 billion across 5 years, with a median of $6.5 billion in 2023.
- Biggest five-year swings in Inventory Average: rose 5.22% in 2021 and later dropped 11.09% in 2024.
- Year by year, Inventory Average stood at $6.9 billion in 2021, then increased by 0.32% to $6.9 billion in 2022, then fell by 5.44% to $6.5 billion in 2023, then decreased by 11.09% to $5.8 billion in 2024, then grew by 3.06% to $6.0 billion in 2025.
- Business Quant data shows Inventory Average for NVS at $6.0 billion in Q4 2025, $5.8 billion in Q4 2024, and $6.5 billion in Q4 2023.